JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 43(2009) N 1 p. 93-100;
G.B. Zavilgelsky, V.Yu. Kotova, S.M. Rastorguev

Antirestriction and antimodification activities of T7 Ocr: Effects of amino acid substitutions in the interface

State Research Center GosNIIgenetika, Moscow, 117545, Russia
Received - 2008-06-05; Accepted - 2008-06-16

The T7 antirestriction protein Ocr, encoded by 0.3 (ocr) , specifically inhibits ATP-dependent type I restriction-modification systems. T7 0.3 (ocr) was cloned in pUC18. Ocr inhibited both restriction and modification activities of the type I restriction-modification system (EcoKI) in Escherichia coli K12. The Ocr F53D A57E mutant was obtained and proved to inhibit only restriction activity of EcoKI. The 0.3 (ocr) and Photorhabdus luminescens luxCDABE genes were cloned in pZ-series vectors with the PltetO-1 promoter, strongly controlled by the TetR repressor. The bioluminescence intensity and luciferase content varied up to 5000-fold in E. coli K12 MG1655Z1 tetR+ (pZE21-luxCDABE) cells, depending on the environmental concentration of the inductor anhydrotetracycline. The antirestriction activity of Ocr and Ocr F53D A57E was studied as a function of their concentration in the cell. The dissociation constant Kd, characterizing the binding with EcoKI, differed 1000-fold between Ocr and Ocr F53D A57E (10-10 M versus 10-7 M).

antirestriction proteins, type I restriction-modification enzymes, ardA 0.3 (ocr). luxCDABE, bioluminescence, luciferase



JMB-FOOTER RAS-JOURNALS